期刊文献+

RhoA/ROCK信号通路在左心疾病致大鼠肺动脉高压模型中的作用 被引量:2

The role of Rho A / ROCK pathway in the rat models of left heart disease-associated pulmonary hypertension
下载PDF
导出
摘要 目的探讨Rho A/ROCK信号通路在左心疾病相关的大鼠肺动脉高压模型中的表达水平和作用。方法 3-4周龄雄性SD大鼠20只,体重90-100 g,随机分为对照组(C组:n=10)、肺高压组(H组:n=10)。H组采用升主动脉固定缩窄术建造左心疾病相关肺动脉高压大鼠模型,C组大鼠行假手术处理(钛夹固定于血管旁纵隔组织而非升主动脉,其他所有手术操作同H组),在建模后60 d,对各组大鼠进行血流动力学(右心室收缩压、肺动脉压力)检测,处死大鼠并用PBS行在体心肺灌洗致双肺变白,左肺组织固定于4%多聚甲醛行病理切片以观察肺组织病理形态学变化、右肺组织冻存以备生物分子学检测(Rho激酶mRNA、Rho A mRNA、ET-A受体mRNA)。结果与C组相比,H组肺动脉压力、右心室收缩压明显增高(P〈0.01),肺小动脉壁明显增厚,肺小动脉管腔狭窄甚至闭塞,管壁肥厚指数明显增大(P〈0.01);与C组相比,H组肺组织的Rho激酶mRNA表达水平明显增加,Rho A mRNA、ET-A受体mRNA表达水平亦明显增加,差异均有统计学意义(P〈0.01)。结论采用升主动脉固定缩窄术成功建造了左心疾病相关肺动脉高压大鼠模型;与C组相比,H组肺小血管壁明显增厚,肺组织的Rho激酶mRNA、Rho A mRNA、ET-A受体mRNA表达明显增高,该信号通路可能参与了左心疾病相关肺动脉高压的形成过程。 Objective To investigate the role of RhoA /Rho-kinase pathway in rat models of left heart disease-associated pulmonary hypertension( PH-LHD). Methods Twenty male SD rats( 3- 4 week-old,90- 100 g) were randomly divided into two groups( 10 rats in each group) : the group C( control group) with sham operation,and group H( pulmonary arterial hypertension). The rat model of left heart disease-associated pulmonary hypertension was established by supracoronary aortic banding in the group H,and the sham surgery was applied for the rats in the group C( The titanium clip wasfixed at the mediastinal tissue adjacent to the artery rather than the ascending aorta). On day 60 after the operation,the cardiac functions,including right ventricular systolic pressure and pulmonary artery pressure were evaluated. After that,all rats were sacrificed and treated with cardiopulmonary lavage in vivo until the lung became white. Then the left lung tissues were fixed in 4% paraformaldehyde for pathological observation while the right lung tissues were frozen for mRNA detection. Results Compared with the group C,both ventricular systolic pressure and pulmonary artery pressure in the group H were increased significantly( P〈0. 01). Pathological data demonstrated that the pulmonary artery walls in H group were much thicker than that in the group C. Moreover,vascular wall hypertrophy index in the group H was increased greatly compared with that in the group C( P〈0. 01). QPCR data showed that mRNA levels of Rho kinase,RhoA and ET-A R in the group H were up-regulated compared with the group C( P〈0. 01). Conclusions Rat model of left heart disease-associated pulmonary arterial hypertension can be successfully established by supracoronary aortic banding. Rho-kinase-mediated pathway may contribute to the pathogenesis and progress of left heart disease-associated pulmonary arterial hypertension.
出处 《中国实验动物学报》 CAS CSCD 北大核心 2015年第6期612-616,共5页 Acta Laboratorium Animalis Scientia Sinica
基金 科技部国际合作项目(2012DFG31440) 上海市科委(13411951402) 上海市领军人才(2012053) 上海市浦东新区国际合作项目(Pkj2013-z03)
关键词 肺动脉高压 升主动脉缩窄 RHO激酶 RHO A 大鼠 Pulmonary arterial hypertension Supracoronary aortic banding Rho kinase RhoA Rat
  • 相关文献

参考文献19

  • 1Raja SG, Dreyfus GD. Current status of bosentan for treatment ofpulmonary hypertension [ J]. Ann Card Anaesth,2008,11:6-14.
  • 2Duong-Quy S, Bei Y , Liu Z, et al. Role of Rho-kinase and itsinhibitors in pulmonary hypertension [J]. Pharmacol Ther,2013,137: 352 -364.
  • 3Nagaoka T, Gebb SA, Kaxoor V,et al. Involvement of RhoA/Rho kinase signaling in pulmonary hypertension of the fawn-hood-ed rat [ J]. J Appl Physiol,2006, 100: 996 - 1002.
  • 4Nagaoka T, Morio Y , Casanova N , et al. Rho/Rho kinase signa-ling mediates increased basal pulmonary vascular tone in chroni-cally hypoxic rats [ J ] . Am J Physiol Lung Cell Mol Physiol,2004, 287: L665 - L672.
  • 5Hyvelin JM, Howell K, Nichol A, et al. Inhibition of Rho-ki-nase attenuates hypoxia-induced angiogenesis in the pulmonarycirculation. Circ Res ,2005 ;97 : 185 -191.
  • 6Nagaoka T, Fagan KA , Gebb SA, et al. Inhaled Rho kinase in-hibitors are potent and selective vasodilators in rat pulmonary hy-pertension [J]. Am J Respir Crit Care Med ,2005 , 171 : 494 -499.
  • 7Barst RJ, McGoon M , Torbicki A, et al. Diagnosis and differen-tial assessment of pulmonary arterial hypertension [ J ]. J Am CollCardiol, 2004, 43: 40S-47S.
  • 8McLaughlin VV, Archer SL, Badesch DB, et ai. ACCF/AHA2009 expert consensus document on pulmonary hypertension: ureport of the American College of Cardiology Foundation TaskForce on Expert Consensus Documents and the American HearlAssociation developed in collaboration with the American Collegeof Chest Physicians; American Thoracic Society, inc. ; and thePulmonary Hypertension Association [J]. J Am Coll Cardiol,2009,53: 1573 - 1619.
  • 9Mita S , Kobayashi N , Yoshida K , et al. Cardioprotective mecha-nisms of Rho-kinase inhibition associated with eNOS and oxida-tive stress-LOX-1 pathway in Dahl salt-sensitive hypertensive rals[J]. J Hypertens, 2005, 23; 87 -96.
  • 10张蕙,陈良万.左心疾病所致的肺动脉高压大鼠模型的制备方法[J].临床和实验医学杂志,2014,13(5):352-355. 被引量:2

二级参考文献11

  • 1袁志敏,吕渠霞.心力衰竭的现代观点与诊治进展[J].心血管病学进展,1994,15(3):149-153. 被引量:52
  • 2Hisaoka T, Yano M, Ohkusa T, et al. Enhancement of Rho/Rho kinase system in regulation of vascular smooth muscle contraction in tachycardia-induced heart failure. Cardiovasc Res, 2001,49: 319-329.
  • 3Suematsu N, Satoh S, Kinugawa S, et al. Alpha1-adrenoceptor-Gq-RhoA signaling is upregulated to increase myofibrillar Ca2+ sensitivity in failing hearts. Am J Physiol Heart Circ Physiol, 2001, 281: H637- H646.
  • 4Touyz RM, Fareh J, Thibault G, et al. Intracellular Ca^2+ modulation by angiotensin Ⅱ and endothelin-1 in cardiomyocytes and fibroblasts from hypertrophied hearts of spontaneously hypertensive rats. Hypertension, 1996, 28: 797-805.
  • 5Amano M, Ito M, Kimura K, et al. Phosphorylation and activation of myosin by Rho-associated kinase(Rho-kinase). J Biol Chem, 1996, 271: 20246-20249.
  • 6Solaro RJ. Myosin light chain phosphatase: a Cinderella of cellular signaling. J Circ Res, 2000, 87:173-175.
  • 7Shimokawa H. Rho-kinase as a novel therapeutic target in treatment of cardiovascular diseases. Cardiovasc Pharma,2002,39: 319-327.
  • 8Arai M, Matsui H, Periasamy M. Sarcoplasmic reticulum gene expression in cardiac hypertrophy and heart failure. J Circ Res, 1994, 74: 555-564.
  • 9谢江,胡大一,牛丽丽,曲素萍,王生浩,刘双.Mesenchymal Stem Cells Attenuate Vascular Remodeling in Monocrotaline-induced Pulmonary Hypertension Rats[J].Journal of Huazhong University of Science and Technology(Medical Sciences),2012,32(6):810-817. 被引量:5
  • 10包伟珂,柏树令,王军,谷春久.升主动脉缩窄鼠模型制作及临床意义[J].中国临床解剖学杂志,1999,17(1):66-67. 被引量:28

共引文献75

同被引文献24

引证文献2

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部